Sutures, commonly known as stitches, are medical devices which are used for the closure of wounds. Suture heal the tissues and keep the wound closed together. Suturing is the most adaptable, least expensive and most widely used technique of securing tissue during an operative procedure. They are mainly used on the skin, internal tissues, organs and blood vessels. Sutures are tied on the skin with the help of a needle available in various size, shapes and are manufactured with different materials. Sutures are normally classified into two types, absorbable and non-absorbable. Absorbable sutures are those which are dissolved in the body by enzymatic reactions or hydrolysis. They can further be classified on the basis of their construction, either mono-filament or multi-filament, coating provided and also whether they are made from natural or synthetic materials. Choice of suture material depends on numerous factors, such as tissue type, infection risk, and personal preferences the surgical needle allows for the correct positioning of the suture material within a tissue. Sutures can also be classified on the basis of their usage e.g. cardiovascular sutures, ophthalmic sutures, general sutures, orthopedic sutures etc...
Due to rapid increase in the incidents of accidents, surgeries, heart transplant and organ transplant the global surgical sutures market is predictable to have a constructive growth over the forecast years.
Increasing accidents and surgeries expected to fuel the surgical suture market
According to World Health Organization (WHO) in 2017, yearly around 1.25 million people die and more than 20 to 50 million people experience severe injuries, due to road traffic crash. Furthermore, surgical sutures are extremely essential for the closure of wounds and injuries occurred in accidents. With the increase in the number of accidents, wherein the use of surgical sutures are high, thus lead to significant growth of surgical sutures market.
According to the annual plastic surgery procedural statistics by American Society of Plastic Surgeons (ASPS), there were 15.9 million surgical and minimally-invasive cosmetic procedures performed in the United States in 2015, 2.0% increase over 2014. The increasing trend of cosmetic and plastic surgery are also expected to drive the surgical suture market in coming years.
Cases of cardiovascular surgeries, heart transplant and organ transplant are rapidly increasing with the growing elderly population which is expected to fuel the surgical sutures market. According to National Center for Biotechnology Information (NCBI) there are some unexpected tissue reactions (inflammation, granuloma, extrusion, fistula, abscess) in the vicinity of Vicryl, suture material (8 cases with Vicryl, 4 cases with Vicryl plus), that are inhibiting the market growth of surgical sutures.
Surgical suture market taxonomy:
By Product Type
By Application
By Material
By Raw Origin
By End User
Regionals growth engines for surgical sutures market
Regional segmentation of surgical suture market by Coherent Market Insights comprises, North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Africa is expected to dominate the surgical sutures market by 2018 due to the increasing incidents of accidents. According to WHO Global Status Report On Road Safety 2015, the incidents of accidents in low- and middle-income countries are more and the accident rate in Africa is highest among all the other regions, which is expected to fuel the surgical sutures market in estimated period of time.
Asia Pacific is expected to follow surgical sutures market in the estimated period of time due to increase in sports activities and there are more chances of knee cartilage injury, which can fuel the surgical suture market in future. With the increasing trend of plastic surgery, North America is expected to have a high growth in surgical suture market in future.
Key players of surgical sutures market
There are numerous players existing across the world. Some of the leading companies are Johnson and Johnson, Lotus Surgicals, 3M healthcare, Derma Sciences, SMB Corporation Of India, Smith & Nephew, Molnlycke healthcare, Dolphin Sutures , Riverpoint Medical, B. Braun Melsungen AG and Covidien. In August 21, 2017 – Ethicon, part of the Johnson & Johnson Medical Devices Companies, U.S. launched the ProxiSureTM Suturing Device.
Share
About Author
Manisha Vibhute is a consultant with over 5 years of experience in market research and consulting. With a strong understanding of market dynamics, Manisha assists clients in developing effective market access strategies. She helps medical device companies navigate pricing, reimbursement, and regulatory pathways to ensure successful product launches.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients